Off-label, but on-target: Use of regadenoson with exercise

ISSN： 1071-3581

Source： Journal of Nuclear Cardiology, Vol.20, Iss.2, 2013-04, pp. : 179-181

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of regadenoson in end-stage renal disease

By Iskandrian Ami

Journal of Nuclear Cardiology, Vol. 20, Iss. 2, 2013-04 ,pp. : 182-184

Springer Publishing Company

Access to resources Recommend Favorite

Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial

By Ross M.

Journal of Nuclear Cardiology, Vol. 20, Iss. 2, 2013-04 ,pp. : 197-204

Springer Publishing Company

Access to resources Recommend Favorite

Haftungsrechtliche Maßstäbe beim “Off-off”-label-Use trotz Verfügbarkeit eines indikationsspezifisch zugelassenen Arzneimittels

By Koenig Christian

MedR - Medizinrecht, Vol. 26, Iss. 6, 2008-06 ,pp. : 404-404

Springer Publishing Company

Access to resources Recommend Favorite

Regadenoson pharmacologic stress for myocardial perfusion imaging: A three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise

By Thompson Randall

Journal of Nuclear Cardiology, Vol. 20, Iss. 2, 2013-04 ,pp. : 214-221

Springer Publishing Company

Access to resources Recommend Favorite

Keine Leistungspflicht der GKV für Off-Label-Use beim Hyperaktivitätsund Aufmerksamkeitsdefizit-Syndrom (ADHS)

MedR - Medizinrecht, Vol. 25, Iss. 9, 2007-09 ,pp. : 563-566

Springer Publishing Company

Access to resources Recommend Favorite